FDA inspection

Centaur Pharmaceuticals Private Ltd.: FDA inspection ending Jan 17, 2020

FDA inspection 1115257 · Voluntary Action Indicated (VAI) · Hinjevadi

Key facts

Inspection ID 1115257
Firm Centaur Pharmaceuticals Private Ltd.
FEI number 3008861619
Address Plot 4, International Biotech Park
City Hinjevadi
Fiscal year 2020
Inspection end date Jan 17, 2020
Classification Voluntary Action Indicated (VAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections